Trading in the shares of 80 Mile (LON: 80M) is moving from SETSqx to SETS. This should help to improve liquidity. The share price jumped 17.15 to 1.47p.
Video monetisation platform provider SEEEN (LON: SEEN) and Tiger Tracks have signed a strategic collaboration and reseller partnership. This will enable video content to be used in performance marketing campaigns to improve returns. The share price increased 12.5% to 4.5p.
Gold recovery company Goldplat (LON: GDP) increased interim revenues by 53% to £45.2m, while pre-tax profit improved from £1.97m to £4.7m. Revenues in South Africa nearly trebled. Ghana revenues were lower due to a change in the basis of sales, while errors in sampling led to a much lower profit contribution. Net cash was £4.81m at the end of 2025. Goldplat is expanding in Brazil. The share price rose 10.4% to 13.25p.
Pawnbroker Ramsdens Holdings (LON: RFX) has published a second update in two months and it has sparked another forecast increase. Full year pre-tax profit is expected to be £24m, compared with £21.1m previously. Precious metals buying continues to boom with a 50% increase in volumes. Jewellery retail is 25% ahead, while pawnbroking is at record levels and forex is in line with expectations. The share price gained 10.3% to 402.5p.
Great Western Minerals (LON: GWMO) has extended the Defender Pine Crow tungsten project area in Nevada. This extends the northern and eastern boundaries of the existing project area. The share price is 9.68% higher at 1.7p. Trading in the shares will soon start on the US OTC Market.
Digital advertising services provider Dianomi (LON: DNM) improved its performance in the second half of 2025 and the 2025 loss will be lower than anticipated. Net cash is £5.8m. A loss of £600,000 is forecast with a similar loss next year despite around 10% growth in forecast revenues. Dianomi in conjunction with Dappier intends to launch an ad-enabled AI chatbot for publisher websites. The share price improved 3.85% to 13.5p.
FALLERS
Retail software provider itim Group (LON: ITIM) says 2025 revenues will be below 2024 levels at around £17.5m due to delays in contract wins. Former AIM-quoted retailer Quiz went into administration and that has increased the expected loss to £500,000. Cost savings could help itim breakeven in 2026 on limited growth in revenues. The share price dived 14.75 to 29p.
Futura Medical (LON: FUM) has been granted the formal US patent for erectile dysfunction treatment Eroxon and formulation derivatives. This should trigger a $2.5m milestone payment from US licensee Haleon. The share price dipped 3.96% to 1.1525p.